semaglutide tablet brand name RYBELSUS® (semaglutide) tablets 7 mg or 14 mg List Price & Insurance Coverage Explained Semaglutide Tablets

6,7 In June 2022, the TGA announced a subsequent shortage of dulaglutide

Typically, Semaglutide GLP-1 injections are recommended for individuals with a BMI of 30 or higher, or 27 or higher with weight-related health conditions

More than half of GLP-1 users said it was difficult to afford the drugs

Prescribing Ozempic specifically for weight loss in non-diabetic patients constitutes off-label use, which, while legal, typically affects insurance coverage and requires careful clinical justification

Nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion, bloating, and reflux appear prominently in current prescribing information for semaglutide and tirzepatide